Immunic’s (IMUX) Buy Rating Reiterated at HC Wainwright
HC Wainwright reaffirmed their buy rating on shares of Immunic (NASDAQ:IMUX – Free Report) in a research report report published on Friday morning,Benzinga reports. The firm currently has a $10.00 price objective on the stock. Several other brokerages also recently weighed in on IMUX. D. Boral Capital reissued a “buy” rating and issued a $17.00 […]
HC Wainwright reaffirmed their buy rating on shares of Immunic (NASDAQ:IMUX – Free Report) in a research report report published on Friday morning,Benzinga reports. The firm currently has a $10.00 price objective on the stock. Several other brokerages also recently weighed in on IMUX. D. Boral Capital reissued a “buy” rating and issued a $17.00 […]
